Press Releases

Sep 20, 2019

The Lancet Publishes Results from Two Positive Phase 3 Trials of Dupixent® (dupilumab) in Severe Chronic Rhinosinusitis with Nasal Polyps (CRSwNP)
Sep 18, 2019

Educational campaign helps teens and their caregivers tackle the everyday challenges of living with moderate-to-severe atopic dermatitis

Understand AD program brings together a team of experts to help a teen with severe atopic dermatitis (AD) and his parents navigate the disease
Sep 16, 2019

Sanofi and Abbott partner to integrate glucose sensing and insulin delivery technologies to help change the way diabetes is managed

- Collaboration aims to provide a connected device experience for millions of people living with diabetes using insulin
Aug 28, 2019

U.S. District Court invalidates Amgen patent claims targeting PCSK9

Court rules in favor of Sanofi and Regeneron in ongoing Praluent® (alirocumab) patent litigation
Aug 6, 2019

Dupixent® (dupilumab) showed positive topline results in Phase 3 trial of children aged 6 to 11 years with severe atopic dermatitis

U.S. FDA submission for children planned for 4Q 2019

Show per page

Print
Email page
RSS